Skip to content
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Neurology · Focal aware sensory seizures

What If Medication Partly Controls Focal Sensory Seizures?

At a Glance

When focal sensory seizures continue after a first medicine, the care team checks the dose, missed doses, drug interactions, and whether the events are truly seizures. Treatment may be adjusted, switched, or combined; ongoing seizures after two adequate trials may lead to epilepsy-center referral.

Experiencing partial improvement—where your first anti-seizure medication (ASM) reduces your focal sensory seizures (also called focal aware sensory seizures) but doesn’t stop them completely—is common, though it can be frustrating and frightening. If this happens, it does not automatically mean the medication has failed or that your epilepsy cannot be controlled. Your care team will systematically review your medication dose, confirm that you are taking it as prescribed, check for interactions with other drugs, and re-evaluate whether the remaining episodes are truly epileptic seizures [1][2]. Depending on what they find, they may adjust your dose, switch you to a different medication, or add a second one [3][4].

Important Safety Warning: Never change or stop your anti-seizure medication on your own. Abruptly stopping can cause dangerous seizure worsening or withdrawal effects. Always contact your prescriber or pharmacist for guidance if you miss a dose, vomit after taking a pill, or experience severe side effects. Seek emergency help immediately for a seizure lasting 5 minutes or longer, repeated seizures without recovery, serious injury, breathing trouble, a seizure in water, or if you develop a severe rash, facial swelling, or suicidal thoughts.

Reviewing the Basics: Dose, Adherence, and Interactions

Before changing your treatment plan, your doctor will want to ensure your current medication has had a fair chance to work.

  • Dose Titration: Anti-seizure medications are typically started at a very low dose and increased (titrated) slowly [4]. This slow approach helps your body adjust and minimizes side effects like drowsiness or dizziness [4][5]. You might still have seizures simply because you have not yet reached the target dose (the specific medication amount recommended for your age, weight, and health condition).
  • Adherence: Missing doses, taking them at inconsistent intervals, or vomiting can lead to partial seizure control [1].
  • Medication Interactions: Drug interactions are highly medication-specific. Some everyday medicines—such as certain antibiotics, hormonal birth control, blood thinners, or over-the-counter supplements—can interact with your ASM [6][7]. For instance, some ASMs can make hormonal contraception less effective, while estrogen-containing birth control can lower the levels of certain ASMs (like lamotrigine) in your blood [8][9]. Always check with a pharmacist before taking anything new, and discuss pregnancy planning with your neurologist early.

Re-evaluating the Episodes

If your dose is optimal and you are taking it as prescribed, your care team will investigate whether the remaining episodes are actually epileptic seizures [10]. Reassessing your diagnosis is a routine safety step, not a dismissal of your experience. Other conditions can cause temporary symptoms that mimic focal seizures:

  • Migraine auras, which can cause visual changes or tingling that spreads [11].
  • Functional or dissociative seizures, which are real, involuntary physical events related to altered brain-body functioning rather than epileptic electrical discharges [12]. They are not intentionally produced, can coexist with epilepsy, and require respectful specialist assessment.
  • Syncope (fainting) or heart rhythm issues, which can cause sudden sensory changes or loss of awareness [13].
  • Medication side effects, as some ASMs can cause dizziness, confusion, or unusual physical sensations that feel like an episode [14].

To help confirm the diagnosis, your doctor might order a prolonged video-EEG or an MRI. While a short, routine EEG often appears normal in people with epilepsy, a longer video-EEG can be useful if it captures a typical event [15]. However, some focal aware sensory seizures are so deep or small they do not show up clearly on a scalp EEG, meaning this test is just one helpful tool, not a guaranteed yes/no answer.

Next Steps: Adjust, Switch, or Combine?

If the remaining events are confirmed to be focal sensory seizures, your doctor will decide the next steps based on your specific situation.

Approach When It Is Commonly Considered
Dose Optimization The medicine reduces seizures, you tolerate it well, and you haven’t reached the maximum recommended or target dose. Your doctor will carefully titrate it higher [4].
Switching (Substitution) The medicine causes unacceptable side effects, or provides no meaningful benefit after an adequate, tolerated trial. The old drug is slowly tapered down while a new one is introduced [3].
Adding (Adjunctive Therapy) The medicine helps significantly and is well-tolerated, but doesn’t completely stop seizures. A second medication is added [3].

When adding a medication, the choice is highly individualized based on your specific seizure type, side effects, and health conditions; there is no universally proven “best” combination [16][17].

Safety and Tracking Your Episodes

Because your episodes are continuing, discuss day-to-day safety with your doctor. Even if your seizures are primarily sensory, you must ask how they affect driving rules (which vary by local law), and take precautions regarding swimming, bathing alone, working at heights, or operating machinery.

To make the best treatment decisions, use a seizure diary to track the dates, times, and exact feelings (e.g., tingling, smells, fear) of your episodes, and how long they last [18][2]. If your episodes include any physical movements, having a family member safely record a video on a smartphone can provide critical clues [15].

Appointment Preparation Checklist:

  • Bring the exact names and doses of your medications and supplements.
  • Bring your seizure diary and any safe video recordings or witness descriptions.
  • Note down any missed doses, vomiting, sleep patterns, alcohol use, or illnesses.

When Medications Aren’t Enough

If you have tried two appropriately chosen, adequately dosed, and tolerated medication regimens (whether alone or in combination) and they fail to achieve seizure freedom, this is medically defined as drug-resistant epilepsy [19].

At this point, experts recommend a referral to a specialized epilepsy center. This allows for a more detailed review and does not automatically mean you will need surgery. A specialist team can explore advanced options tailored to you, such as epilepsy surgery, dietary therapies, or neuromodulation (specialized implanted devices that help regulate brain electrical activity) [2][20].

Common questions in this guide

Does partial control mean my first seizure medicine is not working?
Not necessarily. Partial improvement can mean the dose is not yet optimized, doses are being missed, another medicine is interacting, or the remaining events have a different cause. A prescriber should review these possibilities before deciding that the treatment has failed.
Can I raise or stop my seizure medicine if I still have episodes?
Do not raise, lower, or stop it without speaking with your prescriber or pharmacist. The clinician may slowly increase the dose, replace it with another medicine, or add a second medicine. Abrupt stopping can worsen seizures or cause withdrawal effects.
What tests can show whether the remaining episodes are seizures?
A clinician may review a detailed episode history and order prolonged video-EEG or an MRI. A routine EEG can be normal in epilepsy, and some focal aware sensory seizures do not appear clearly on a scalp EEG, so one test cannot always settle the question.
Would my doctor switch medicines or add another one?
Switching is often considered when the first medicine causes unacceptable side effects or gives no meaningful benefit after an adequate trial. Adding a second medicine may be considered when the first helps and is tolerated but does not fully stop the seizures. The choice depends on seizure type, other health conditions, and side effects.
When do ongoing seizures lead to an epilepsy-center referral?
After two appropriately chosen, adequately dosed, and tolerated medicine regimens fail to stop seizures, clinicians may classify the epilepsy as drug-resistant. A specialized epilepsy center can review the diagnosis and treatment options. Referral does not automatically mean surgery; options can also include dietary therapy or implanted devices that help regulate brain activity.
What safety changes should I make while these seizures continue?
Ask about driving rules in your area and use caution with swimming, bathing alone, heights, and machinery. Keep a seizure diary and, when safe, have a witness record an event to help clinicians understand it. Seek emergency help for a seizure lasting 5 minutes or longer, repeated seizures without recovery, breathing trouble, serious injury, a seizure in water, or severe rash, facial swelling, or suicidal thoughts.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on partial sensory epilepsy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Am I currently at the target dose for this medication, and if not, what is the expected timeline for gradually increasing it?
  2. 2.If we need to adjust my treatment, do you recommend switching to a new medication or adding a second one (adjunctive therapy), and why?
  3. 3.Could any of my other daily medications, hormonal birth control, or over-the-counter supplements be interacting with my anti-seizure medication?
  4. 4.At what point would we consider ordering a prolonged video-EEG or MRI to reassess these episodes?
  5. 5.If my current episodes continue, are there specific daily activities—like driving, swimming, or working at heights—that I need to restrict or avoid?
  6. 6.Will you refer me to a specialized epilepsy center if a second medication trial does not stop these episodes?

References

References (20)
  1. 1

    Epilepsy in a health district in North-West Cameroon: Clinical characteristics and treatment gap.

    Angwafor SA, Bell GS, Ngarka L, et al.

    Epilepsy & behavior : E&B 2021; (121(Pt A)):107997 doi:10.1016/j.yebeh.2021.107997.

    PMID: 33994085
  2. 2

    Epilepsy in adults.

    Thijs RD, Surges R, O'Brien TJ, Sander JW

    Lancet (London, England) 2019; (393(10172)):689-701 doi:10.1016/S0140-6736(18)32596-0.

    PMID: 30686584
  3. 3

    Cognitive and behavioral effects of the anti-epileptic drug cenobamate (YKP3089) and underlying synaptic and cellular mechanisms.

    Song WS, Cho YS, Oh SP, et al.

    Neuropharmacology 2022; (221()):109292 doi:10.1016/j.neuropharm.2022.109292.

    PMID: 36244413
  4. 4

    Brivaracetam: a novel antiepileptic drug for focal-onset seizures.

    Stephen LJ, Brodie MJ

    Therapeutic advances in neurological disorders 2018; (11()):1756285617742081 doi:10.1177/1756285617742081.

    PMID: 29399049
  5. 5

    Antiseizure Medications for Adults With Epilepsy: A Review.

    Kanner AM, Bicchi MM

    JAMA 2022; (327(13)):1269-1281 doi:10.1001/jama.2022.3880.

    PMID: 35380580
  6. 6

    A review of pharmacokinetic drug interactions between antimicrobial and antiseizure medications in children.

    Zaccara G, Lattanzi S

    Epileptic disorders : international epilepsy journal with videotape 2021; (23(2)):229-256 doi:10.1684/epd.2021.1261.

    PMID: 33814360
  7. 7

    Practices in the prescription of antiseizure medications: is it time to change?

    Pinto LF, Silva LS, João RB, et al.

    Arquivos de neuro-psiquiatria 2024; (82(6)):1-10 doi:10.1055/s-0043-1777806.

    PMID: 38531396
  8. 8

    A review of the drug-drug interactions of the antiepileptic drug brivaracetam.

    Moseley BD, Chanteux H, Nicolas JM, et al.

    Epilepsy research 2020; (163()):106327 doi:10.1016/j.eplepsyres.2020.106327.

    PMID: 32361205
  9. 9

    Inconsistent reporting of drug-drug interactions for hormonal contraception and antiepileptic drugs - Implications for reproductive health for women with epilepsy.

    Decker BM, Acton EK, Davis KA, Willis AW

    Epilepsy & behavior : E&B 2021; (114(Pt A)):107626 doi:10.1016/j.yebeh.2020.107626.

    PMID: 33309232
  10. 10

    Instruction manual for the ILAE 2017 operational classification of seizure types.

    Fisher RS, Cross JH, D'Souza C, et al.

    Epilepsia 2017; (58(4)):531-542 doi:10.1111/epi.13671.

    PMID: 28276064
  11. 11

    Epilepsy and migraine: a diagnostic and therapeutic challenge.

    Pascarella A, Marsico O, Abelardo D, et al.

    Frontiers in pharmacology 2025; (16()):1649543 doi:10.3389/fphar.2025.1649543.

    PMID: 40949139
  12. 12

    A complex case with generalized epilepsy, probable focal seizures, and functional seizures.

    Elshetihy A, Nergiz L, Cloppenborg T, et al.

    Epilepsy & behavior reports 2024; (27()):100684 doi:10.1016/j.ebr.2024.100684.

    PMID: 38953098
  13. 13

    Focal seizures producing loss of wakefulness without ictal asystole: Does temporal lobe syncope exist?

    Bregianni M, Lagarde S, Pizzo F, et al.

    Epilepsy research 2022; (186()):107015 doi:10.1016/j.eplepsyres.2022.107015.

    PMID: 36063590
  14. 14

    The Initial Experience of Eslicarbazepine in Children at Three Canadian Tertiary Pediatric Care Centers.

    Nyakeri Y, Xu Q, Nouri M, et al.

    Journal of child neurology 2025; (40(1)):39-48 doi:10.1177/08830738241282903.

    PMID: 39376092
  15. 15

    Diagnostic yield of seizure recordings and neuroimaging in patients with focal epilepsy without interictal epileptiform discharges.

    Suzuki M, Jin K, Kitazawa Y, et al.

    Epilepsy & behavior : E&B 2020; (112()):107468 doi:10.1016/j.yebeh.2020.107468.

    PMID: 33181891
  16. 16

    Pharmacological treatment of focal epilepsy in adults: an evidence based approach.

    Mula M

    Expert opinion on pharmacotherapy 2021; (22(3)):317-323 doi:10.1080/14656566.2020.1829594.

    PMID: 32990097
  17. 17

    Which treatment strategy in patients with epilepsy with focal seizures uncontrolled by the first anti-seizure medication?

    Zaccara G, Lattanzi S, Brigo F

    Epilepsy & behavior : E&B 2021; (121(Pt A)):108031 doi:10.1016/j.yebeh.2021.108031.

    PMID: 33992932
  18. 18

    Randomized phase 2 study of adjunctive cenobamate in patients with uncontrolled focal seizures.

    Chung SS, French JA, Kowalski J, et al.

    Neurology 2020; (94(22)):e2311-e2322 doi:10.1212/WNL.0000000000009530.

    PMID: 32409485
  19. 19

    Therapeutic strategies during cenobamate treatment initiation: Delphi panel recommendations.

    Steinhoff BJ, Ben-Menachem E, Klein P, et al.

    Therapeutic advances in neurological disorders 2024; (17()):17562864241256733 doi:10.1177/17562864241256733.

    PMID: 38883228
  20. 20

    From syndrome to precision therapy: current and emerging therapeutic options for selected pediatric focal epilepsies.

    Perilli L, Dell'isola GB, Ferrara P, et al.

    Expert opinion on pharmacotherapy 2026; 1-13 doi:10.1080/14656566.2026.2725871.

    PMID: 42649611

This page is for informational purposes only and does not constitute medical advice. A neurologist or prescriber should guide any medication changes and safety decisions for your focal sensory seizures.